Gastrointestinal transit in patients with systemic sclerosis

References

• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202–5.
   PubMed Web of Science ®Google Scholar
• Rosson RS, Yesner R. Peroral Duodenal Biopsy in Progressive Systemic Sclerosis. N Engl J Med 1965;272:391–4.
   PubMedGoogle Scholar
• Cohen S. The gastrointestinal manifestations of scleroderma: pathogenesis and management. Gastroenterology 1980;79:155–66.
   PubMed Web of Science ®Google Scholar
• Poirier TJ, Rankin GB. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Am J Gastroenterol 1972;58:30–44.
   PubMed Web of Science ®Google Scholar
• Trezza M, Krogh K, Egekvist H, Bjerring P, Laurberg S. Bowel problems in patients with systemic sclerosis. Scand J Gastroenterol 1999;34:409–13.
   PubMed Web of Science ®Google Scholar
• Hamel-Roy J, Devroede G, Arhan P, Tetreault L, Duranceau A, Menard HA. Comparative esophageal and anorectal motility in scleroderma. Gastroenterology 1985;88:1–7.
   PubMed Web of Science ®Google Scholar
• D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969;46:428–40.
   PubMed Web of Science ®Google Scholar
• Domsic R, Fasanella K, Bielefeldt K. Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci 2008;53:1163–74.
   PubMed Web of Science ®Google Scholar
• Kaye SA, Lim SG, Taylor M, Patel S, Gillespie S, Black CM. Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Br J Rheumatol 1995;34:265–9.
   PubMedGoogle Scholar
• Marie I, Levesque H, Ducrotte P, Denis P, Benichou J, Hellot MF, Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study. Arthritis Rheum 1998;41:1874–83.
   PubMed Web of Science ®Google Scholar
• Sjolund K, Bartosik I, Lindberg G, Scheja A, Wildt M, Akesson A. Small intestinal manometry in patients with systemic sclerosis. Eur J Gastroenterol Hepatol 2005;17:1205–12.
   PubMedGoogle Scholar
• Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998;93:1085–9.
   PubMed Web of Science ®Google Scholar
• Wegener M, Adamek RJ, Wedmann B, Jergas M, Altmeyer P. Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 1994;39:2209–15.
   PubMed Web of Science ®Google Scholar
• Stathopoulos E, Schlageter V, Meyrat B, Ribaupierre Y, Kucera P. Magnetic pill tracking: a novel non-invasive tool for investigation of human digestive motility. Neurogastroenterol Motil 2005;17:148–54.
   PubMed Web of Science ®Google Scholar
• Hiroz P, Schlageter V, Givel JC, Kucera P. Colonic movements in healthy subjects as monitored by a Magnet Tracking System. Neurogastroenterol Motil 2009;21:838–e57.
   PubMed Web of Science ®Google Scholar
• Guignet R, Bergonzelli G, Schlageter V, Turini M, Kucera P. Magnet Tracking: a new tool for in vivo studies of the rat gastrointestinal motility. Neurogastroenterol Motil 2006;18:472–8.
   PubMed Web of Science ®Google Scholar
• Bercik P, Schlageter V, Mauro M, Rawlinson J, Kucera P, Armstrong D. Noninvasive verification of nasogastric tube placement using a magnet-tracking system: a pilot study in healthy subjects. JPEN J Parenter Enteral Nutr 2005;29:305–10.
   PubMedGoogle Scholar
• Fynne L, Worsoe J, Gregersen T, Schlageter V, Laurberg S, Krogh K. Gastric and small intestinal dysfunction in spinal cord injury patients. Acta Neurol Scand 2011. [Epub ahead of print].
   Google Scholar
• Gregersen T, Gronbaek H, Worsoe J, Schlageter V, Laurberg S, Krogh K. Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors. Scand J Gastroenterol 2011. [Epub ahead of print].
   Google Scholar
• Tan PL, Wigley RD, Borman GB. Clinical criteria for systemic sclerosis. Arthritis Rheum 1981;24:1589–90.
   PubMedGoogle Scholar
• Hinton JM, Lennard-Jones JE, Young AC. A ne method for studying gut transit times using radioopaque markers. Gut 1969;10:842–7.
   PubMed Web of Science ®Google Scholar
• Schuster MM. Atlas of gastrointestinal motility- in health and disease. Breath hydrogen measurement of small bowel transit time. 2011 (Ch 4).
   Google Scholar
• Bortolotti M, Turba E, Tosti A, Sarti P, Brunelli F, Del CL, Gastric emptying and interdigestive antroduodenal motility in patients with esophageal scleroderma. Am J Gastroenterol 1991;86:743–7.
   PubMedGoogle Scholar
• Greydanus MP, Camilleri M. Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 1989;96:110–5.
   PubMed Web of Science ®Google Scholar
• DiMarino AJ, Carlson G, Myers A, Schumacher HR, Cohen S. Duodenal myoelectric activity in scleroderma. Abnormal responses to mechanical and hormonal stimuli. N Engl J Med 1973;289:1220–3.
   PubMedGoogle Scholar
• Madsen JL, Hendel L. Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis. Dig Dis Sci 1992;37:1404–8.
   PubMedGoogle Scholar
• Manetti M, Milia AF, Benelli G, Messerini L, Matucci-Cerinic M, Ibba-Manneschi L. The gastric wall in systemic sclerosis patients: a morphological study. Ital J Anat Embryol 2010;115:115–21.
   PubMedGoogle Scholar
• Roberts CG, Hummers LK, Ravich WJ, Wigley FM, Hutchins GM. A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma). Gut 2006;55:1697–703.
   PubMed Web of Science ®Google Scholar
• Cobden I, Axon AT, Ghoneim AT, McGoldrick J, Rowell NR. Small intestinal bacterial growth in systemic sclerosis. Clin Exp Dermatol 1980;5:37–42.
   PubMed Web of Science ®Google Scholar
• Gough A, Andrews D, Bacon PA, Emery P. Evidence of omeprazole-induced small bowel bacterial overgrowth in patients with scleroderma. Br J Rheumatol 1995;34:976–7.
   PubMedGoogle Scholar
• Kahn IJ, Jeffries GH, Sleisenger MH. Malabsorption in intestinal scleroderma. Correction by antibiotics. N Engl J Med 1966;274:1339–44.
   PubMed Web of Science ®Google Scholar
• Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991;325:1461–7.
   PubMed Web of Science ®Google Scholar
• Gryback P, Jacobsson H, Blomquist L, Schnell PO, Hellstrom PM. Scintigraphy of the small intestine: a simplified standard for study of transit with reference to normal values. Eur J Nucl Med Mol Imaging 2002;29:39–45.
   PubMedGoogle Scholar
• Tougas G, Eaker EY, Abell TL, Abrahamsson H, Boivin M, Chen J, Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000;95:1456–62.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Zinsmeister AR, Greydanus MP, Brown ML, Proano M. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci 1991;36:609–15.
   PubMed Web of Science ®Google Scholar
• Delbende B, Perri F, Couturier O, Leodolter A, Mauger P, Bridgi B, 13C-octanoic acid breath test for gastric emptying measurement. Eur J Gastroenterol Hepatol 2000;12:85–91.
   PubMedGoogle Scholar
• Stotzer PO, Kilander AF. Comparison of the 1-gram (14)C-D-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion 2000;61:165–71.
   PubMed Web of Science ®Google Scholar
• Corazza G, Sorge M, Strocchi A, Gasbarrini G. Glucose-H2 breath test for small intestine bacterial overgrowth. Gastroenterology 1990;98:253–4.
   PubMedGoogle Scholar
• Esposito I, De LA, Di GG, Giaquinto S, De ML, Ferrieri A, Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics. World J Gastroenterol 2007;13:6016–21.
   PubMed Web of Science ®Google Scholar
• Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 1988;95:982–8.
   PubMed Web of Science ®Google Scholar
• Lin HC. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004;292:852–8.
   PubMed Web of Science ®Google Scholar
• Perlemuter G, Cacoub P, Wechsler B, Hausfater P, Piette JC, Couturier D, [Chronic intestinal pseudo-obstruction secondary to connective tissue diseases]. Gastroenterol Clin Biol 2001;25:251–8.
   PubMedGoogle Scholar